Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BioSapien logo — Developing innovative therapies to transform patient care. I...

BioSapien

Developing innovative therapies to transform patient care. Inventor of the MediChip®.

Founded 2018 United States San Diego, United States 12 employees Grant Total: $37.06M Biopharma, Biotechnology +3

General Information

Company Name BioSapien
Founded Year 2018
Location United States San Diego, United States +1
Employees 12
Industries Biopharma, Biotechnology, Pharmaceutical +2
Funding Stage Grant
Social

Get notified when BioSapien moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioSapien

BioSapien is a late-stage pre clinical company with a focus on novel drug delivery platforms. Founded in 2018 and headquartered in the United States, the company's slogan emphasizes its commitment to developing innovative therapies to transform patient care as the inventor of the MediChip®. The company operates in the Biopharma, Biotechnology, Pharmaceutical, VR/AR, and 3D Printing industries. Notably, it received a grant investment on 21 February 2024 from Health Engine. This recent investment may signify growing interest and belief in the potential of BioSapien's ventures.

Taxonomy: Biotech, Drug delivery, 3D printing, Oncology, Cancer treatment, Implantable products, Biodegradable materials, Localized drug delivery, Medical devices, FDA-approved drugs, Innovative therapies, Tissue engineering, Stem cells, Pancreatic cancer, Lung cancer

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
21 Feb 2024
Convertible Note •••••• 1
Investor
19 Jul 2023
Series A •••••• 3
Investor Investor Investor
01 Nov 2022
Seed Round •••••• 10
Investor Investor Investor Investor Investor Investor
•••• •••• 		11 Nov 2021
Grant •••••• 1
Investor
11 Nov 2021

View All 8 Funding Rounds

BioSapien Alternatives & Competitors

BioSapien vs
Focal Medical, Inc. (acquired by Continuity Biosciences)
Focal Medical, Inc. (acquired by Continuity Biosciences) United States

We are developing novel targeted therapeutic products based on our innovative local drug-delivery te...

Series A
4 employees
Biopharma, Biotechnology
BioSapien vs
Bound Therapeutics
Bound Therapeutics United States

Safe and effective next generation RNA therapeutics

3 employees
Biopharma, Biotechnology
BioSapien vs
NanoCube
NanoCube Australia

Transforming cancer diagnostics and treatment with bioinspired nanorobotics

2 employees

FAQ About BioSapien

Developing innovative therapies to transform patient care. Inventor of the MediChip®.
BioSapien was founded in 2018.
BioSapien is headquartered in San Diego, United States.
BioSapien operates in the following industries: Biopharma, Biotechnology, Pharmaceutical, VR/AR, 3D Printing.
BioSapien has approximately 12 employees.
BioSapien has completed 8 funding rounds, raising a total of $37.06M. The latest funding stage is Grant.
Top alternatives and competitors to BioSapien include Focal Medical, Inc. (acquired by Continuity Biosciences), Bound Therapeutics, NanoCube, EPICS Therapeutics, Flow Pharma Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioSapien and Focal Medical, Inc. (acquired by Continuity Biosciences) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioSapien and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy